Bristol Myers Squibb (CELG-RI) Cash from Investing Activities Growth (5y) (2014 - 2026)

Bristol Myers Squibb (CELG-RI) Cash from Investing Activities Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.74%
Dec 31, 2025 34.19%
Sep 30, 2025 -51.54%
Jun 30, 2025 -23.31%
Mar 31, 2025 -23.02%
Dec 31, 2024 56.21%
Sep 30, 2024 -19.59%
Jun 30, 2024 -30.91%
Mar 31, 2024 -82.97%
Dec 31, 2023 1.64%
Sep 30, 2023 -22.77%
Jun 30, 2023 1.12%
Mar 31, 2023 -37.33%
Dec 31, 2022 3.55%
Sep 30, 2022 -75.51%
Jun 30, 2022 22.35%
Mar 31, 2022 19.80%
Dec 31, 2021 90.46%
Sep 30, 2021 -21.54%
Jun 30, 2021 -15.01%